Correlations betweenper capitagreen tea consumption and COVID-19 morbidity/mortality: comparing the strength before and after Omicron emergence

Author:

Storozhuk MaksimORCID

Abstract

AbstractPurposeThere is rapidly growingin vitropharmacological evidence suggesting preventive/therapeutic potential of green tea and its constituent EGCG in battle with COVID-19. The aim of this study was to analyze time course of previously reported correlations betweenper capitagreen tea consumption and COVID-19 morbidity/mortality with a focus on comparing periods of time before (year 2021) and after (years 2022-2023) emergence of Omicron variant.MethodsCorrelations betweenper capitagreen tea consumption and COVID-19 morbidity/mortality were calculated using multiple regression models in a subset (n=84) of countries/territories worldwide with HDI above 0.55. Strength of the correlations for several dates in 2021, 2022 and 2023 was compared.ResultsHigherper capitagreen tea consumption was associated with lower COVID-19 morbidity and mortality. Statistically significant correlations were observed in 2021, 2022 and 2023. As compared to 2021, the strength of both correlations was decreased in 2022 and 2023. On average normalized to 2021 strength of correlation betweenper capitagreen tea consumption and COVID-19 morbidity decreased to 0.60, while normalized strength of correlation betweenper capitagreen tea consumption and COVID-19 morbidity decreased to 0.83.ConclusionOverall, the results of this study are in line within vitropharmacological evidence. Though indirectly, these results at epidemiological level support the idea that green tea consumption may have not only preventive, but also therapeutic value in relation to COVID-19. Nevertheless, because of limitations of this study, this idea still should be considered as a hypothesis requiring further assessment.

Publisher

Cold Spring Harbor Laboratory

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3